Podcast appearances and mentions of Thomas F Patterson

Go online to PeerView.com/JZZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an infectious diseases specialist provides guidance on improving the diagnosis and treatment of invasive fungal infections. Upon completion of this activity, participants will be able to: Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed, Promptly evaluate high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of antifungal therapy, Discuss available diagnostic tests and emerging technologies to ensure early detection of invasive fungal infections, Outline the role of antifungal susceptibility testing in guiding therapeutic decision-making for invasive fungal infections, Optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients with invasive fungal infections through targeted application of kinetic and dynamic principles.

Go online to PeerView.com/JZZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an infectious diseases specialist provides guidance on improving the diagnosis and treatment of invasive fungal infections. Upon completion of this activity, participants will be able to: Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed, Promptly evaluate high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of antifungal therapy, Discuss available diagnostic tests and emerging technologies to ensure early detection of invasive fungal infections, Outline the role of antifungal susceptibility testing in guiding therapeutic decision-making for invasive fungal infections, Optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients with invasive fungal infections through targeted application of kinetic and dynamic principles.

Go online to PeerView.com/JZZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an infectious diseases specialist provides guidance on improving the diagnosis and treatment of invasive fungal infections. Upon completion of this activity, participants will be able to: Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed, Promptly evaluate high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of antifungal therapy, Discuss available diagnostic tests and emerging technologies to ensure early detection of invasive fungal infections, Outline the role of antifungal susceptibility testing in guiding therapeutic decision-making for invasive fungal infections, Optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients with invasive fungal infections through targeted application of kinetic and dynamic principles.

Go online to PeerView.com/JZZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an infectious diseases specialist provides guidance on improving the diagnosis and treatment of invasive fungal infections. Upon completion of this activity, participants will be able to: Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed, Promptly evaluate high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of antifungal therapy, Discuss available diagnostic tests and emerging technologies to ensure early detection of invasive fungal infections, Outline the role of antifungal susceptibility testing in guiding therapeutic decision-making for invasive fungal infections, Optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients with invasive fungal infections through targeted application of kinetic and dynamic principles.

Go online to PeerView.com/JZZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an infectious diseases specialist provides guidance on improving the diagnosis and treatment of invasive fungal infections. Upon completion of this activity, participants will be able to: Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed, Promptly evaluate high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of antifungal therapy, Discuss available diagnostic tests and emerging technologies to ensure early detection of invasive fungal infections, Outline the role of antifungal susceptibility testing in guiding therapeutic decision-making for invasive fungal infections, Optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients with invasive fungal infections through targeted application of kinetic and dynamic principles.

Go online to PeerView.com/JZZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an infectious diseases specialist provides guidance on improving the diagnosis and treatment of invasive fungal infections. Upon completion of this activity, participants will be able to: Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed, Promptly evaluate high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of antifungal therapy, Discuss available diagnostic tests and emerging technologies to ensure early detection of invasive fungal infections, Outline the role of antifungal susceptibility testing in guiding therapeutic decision-making for invasive fungal infections, Optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients with invasive fungal infections through targeted application of kinetic and dynamic principles.

Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider

Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider

Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider